Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018

Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.

In the United States, overall rates of new colorectal cancer cases and deaths from the disease have decreased steadily since 1980, largely owing to recommended colonoscopy screening starting at age 50. For reasons that remain unknown, new cases of, and deaths due to, both colon and rectal cancers have been increasing for younger adults ages 20 to 49.

The study, published Oct. 11 in JAMA Oncology, is among the first epidemiologic analyses of the potential contributors to early-onset colorectal cancer - cases diagnosed under age 50. The researchers found that higher current BMI, BMI at 18 years of age, and weight gain since early adulthood are associated with increased risk of colorectal cancer under age 50.

The researchers included collaborators at the Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital, and Massachusetts General Hospital at Harvard Medical School. The study included data from 85,256 women ages 25 to 44 in the Nurses' Health Study II, which began in 1989. The researchers have collected detailed information on body weight throughout the life course, family and endoscopy histories, and lifestyle factors at study baseline and every two to four years. Up to 2011, doctors diagnosed 114 colorectal cancer cases under age 50.

"Our findings really highlight the importance of maintaining a healthy weight, beginning in early adulthood for the prevention of early-onset colorectal cancer," said co-senior author and cancer epidemiologist Yin Cao, ScD, an assistant professor of surgery in the Division of Public Health Sciences at Washington University. "We hypothesized that the obesity epidemic may partially contribute to this national and global concern in early-onset colorectal cancer rates, but we were surprised by the strength of the link and the contribution of obesity and weight change since early adulthood."

Compared with women with the lowest BMIs (18.5-22.9 kilograms per square meter), women with the highest BMIs (greater than 30) had almost twice the risk of early-onset colorectal cancer. According to the Centers for Disease Control and Prevention, the normal BMI range is 18.5-24.9 kilograms per square meter. BMIs from 25-29.9 are considered overweight, and BMIs greater than 30 are considered obese.

Early-onset colorectal cancer remains relatively rare at about eight cases per 100,000 people, but since these populations do not receive routine screening, cases often are diagnosed at later stages of the disease, making them much more difficult to treat. The researchers estimated that roughly 22 percent of early-onset colorectal cancer could have been prevented had all participants had a normal BMI between 18.5-24.9. On a population scale, this represents thousands of potentially preventable colorectal cancer cases among the younger population. The researchers further found that the higher risk of early-onset colorectal cancer associated with increasing BMI held even among women with no family history of the disease.

The American Cancer Society recently lowered the recommended age at which most people should undergo a first screening colonoscopy. The new guidelines recommend screening beginning at age 45, down from the previous recommendation of age 50. Cao said more research is needed, including additional validation studies as well as cost-benefit analyses, to see if BMI should be considered in deciding the appropriate age an individual should begin screening or complement current screening efforts.

"There are few known risk factors for early-onset colorectal cancer," said Edward Giovannucci, MD, ScD, of the Harvard T.H. Chan School of Public Health. "If the screening age gets pushed before age 50, BMI may be one of the factors to take into account. Yet the cost analysis and risk-benefit analysis for early age of screening remains to be done."

The researchers emphasized that this is an association study -- it does not establish that increasing weight is a cause of early-onset colorectal cancer. It is possible BMI could be serving as a surrogate for other risk factors that may influence colorectal cancer risk, including metabolic syndrome and diabetes, which also have been increasing at the population level.

The researchers said more studies are needed to uncover the best ways to identify young people at high risk of colorectal cancer at younger ages. And since this study was limited to women who were predominantly white, more research is needed to see if these associations hold for men and for diverse racial and ethnic populations.

"Emerging data also suggest that early-onset colorectal cancer may be different on a molecular level from cases diagnosed at older ages," Cao said. "Because early-onset colorectal cancer is rare, we need more collaborative research to understand why case rates and deaths among younger people are increasing and what could be done to slow them down."
-end-
This work was supported by the National Institutes of Health (NIH), grant numbers UM1 CA176726, R01 CA137178, R01 CA205406, R35 CA197735 and K24 DK098311; a Crohn's and Colitis Foundation Senior Investigator Award; a Stuart and Suzanne Steele MGH Research Scholars Award; the Raymond P. Lavietes Foundation; and a National Comprehensive Cancer Network Young Investigator Award.

Liu P, Wu K, Ng K, Zauber AG, Nguyen LH, Song M, He X, Fuchs CS, Ogino S, Willet WC, Chan AT, Giovannucci EL, Cao Y. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncology. Oct. 11, 2018.

Washington University School of Medicine's 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Washington University School of Medicine

Related Colorectal Cancer Articles from Brightsurf:

Colorectal cancer treatment: the winning combinations
Chemotherapy has distressing side effects for patients and increases the risk of developing resistance to the treatment.

A new model to predict survival in colorectal cancer
This signature could be useful in clinical practice, especially for colorectal cancer diagnosis and therapy.

Roadmap to reducing colorectal cancer deaths
The American Gastroenterological Association has outlined a strategy to increase the number of people screened via tests that are more convenient, accurate and less expensive and tailored to people's individual cancer risks.

Study provides new insight on colorectal cancer growth
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth.

Researchers ID target for colorectal cancer immunotherapy
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.

Colorectal cancer partner-in-crime identified
A protein that helps colorectal cancer cells spread to other parts of the body could be an effective treatment target.

Cancer cell reversion may offer a new approach to colorectal cancer treatment
A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a KAIST research team based in South Korea.

A novel pathway to target colorectal cancer
Survival rates for patients with late-stage colorectal cancer are dismal, and new therapeutic strategies are needed to improve outcomes.

Colorectal cancer rates in Canada
The incidence of colorectal cancer among younger adults increased in recent years in this analysis of data from Canadian national cancer registries that included about 688,000 new colorectal cancers diagnosed over more than 40 years.

Cancer drugs promote stem cell properties of colorectal cancer
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells.

Read More: Colorectal Cancer News and Colorectal Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.